Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Compare after-tax performance between ETFs and mutual funds to understand tax efficiency and potential savings for your portfolio.
26,741 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
A price about break out in AI pricing is emerging as competition intensifies. Investors are counting on who can monet...
Charles Schwab is partnering with Cboe to launch S&P 500 yes-or-no binary options, a first-of-its-kind move into pred...
Memory stocks kicked higher Monday, led by SanDisk and Western Digital, as banks turn constructive on the sector. Ana...
What if one cryptocurrency could outgrow Bitcoin and Ethereum combined? This article dives into the drivers, risks, a...
Salesforce unveils a $50 billion buyback as software stocks waver, triggering a fierce debate over whether capital sh...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
A single speech by Jensen Huang can tilt markets. This article explains what these words from Jensen might mean for N...
SpaceX begins trading on Nasdaq under SPCX, aiming to redefine public markets for space technology. Investors weigh s...
Bitcoin led a broad rebound in the crypto market on July 2, 2026, as optimism around AI-driven productivity and easin...
Grok AI’s forecast of a $40K Bitcoin price has ignited a fierce market debate. Analysts say the model’s ultra-bear ca...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...